Product Images Buprenorphine And Naloxone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Buprenorphine And Naloxone NDC 0228-3155 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

round tablets - image 1

round tablets - image 1

The following chemical structure of Buprenorphine HCl, USP has the molecular formula C29H41NO4 • HCl and the molecular weight is 504.10. It is a white or off-white crystalline powder, sparingly soluble in water, freely soluble in methanol, soluble in alcohol, and practically insoluble in cyclohexane. - image 2

The following chemical structure of Buprenorphine HCl, USP has the molecular formula C29H41NO4 • HCl and the molecular weight is 504.10. It is a white or off-white crystalline powder, sparingly soluble in water, freely soluble in methanol, soluble in alcohol, and practically insoluble in cyclohexane. - image 2

The following chemical structure of Naloxone hydrochloride dihydrate, USP has the molecular formula C19H21NO4 • HCl • 2H2O and the molecular weight is 399.87. It is a white to slightly off-white powder and is freely soluble in water, soluble in alcohol, and practically insoluble in toluene and ether. - image 3

The following chemical structure of Naloxone hydrochloride dihydrate, USP has the molecular formula C19H21NO4 • HCl • 2H2O and the molecular weight is 399.87. It is a white to slightly off-white powder and is freely soluble in water, soluble in alcohol, and practically insoluble in toluene and ether. - image 3

round tablet - image 4

round tablet - image 4

round tablet - image 5

round tablet - image 5

2 - image 6

2 - image 6

1 - image 7

1 - image 7

This text appears to be a medication label for Buprenorphine and Naloxone sublingual tablets. It includes information such as the drug's unique identification number, dosage, and storage instructions. It also emphasizes to keep the medication out of reach of children, as accidental ingestion could lead to the need for emergency medical care.*

1 - image 8

1 - image 8

This is a medication with the NDC code 0228-3155-03 consisting of buprenorphine and naloxone tablets to treat opioid dependence. It has specific guidelines on the dosage and administration, and should be dispensed in light-resistant containers. Additionally, it needs to be kept out of the reach of children. This particular product has 30 tablets and was manufactured for Teva Pharmaceuticals, with a product code of 52-0487.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.